Clinical study of Fangxia Dihuang Decoction intervention on psychosomatic symptoms of breast cancer patients undergoing chemotherapy

Phase 2

• Conditions: breast cancer

• Registration Number: ITMCTR2200005877
• Lead Sponsor: Xiamen Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

(1) Women aged 18-70;
(2) Postoperative pathological diagnosis of breast cancer, clinical stage II to III;
(3) Postoperative adjuvant chemotherapy is planned;
(4) ECOG score 0-2;
(5) Consistent with the TCM syndrome diagnosis of liver and kidney Yin deficiency, blood stasis and heat disturbing the spirit;
(6) Sign informed consent to participate in this study voluntarily.,

Exclusion Criteria

(1) complicated with serious diseases of the heart, cerebrovascular, liver, kidney, hematopoietic system or other malignant tumors;
(2) people who are allergic to the study drugs;
(3) those who do not know the diagnosis of breast cancer;
(4) with a history of serious mental disorders;
(5) Have received psychological treatment or psychological intervention in the past three months;
(6) Pregnant and lactating women.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Health Questionnaire Depression Module;Generalized Anxiety Disor-der Scale;

Secondary Outcome Measures

Name	Time	Method
Chinese medicine symptom complex score;Brief Fatigue Inventory-Chinese;Prospective and Retrospective Memory Questionnaire;Athens Insomnia Scale;